Trending Now
Day: January 4, 2024
Recursion Adds New Chemical Entity Targeting Fibrotic Diseases to Late Discovery Pipeline
January 4, 2024
Potential First-in-Class Novel Molecule with Novel Target In-Licensed from Collaboration with Bayer SALT LAKE CITY, Jan. 04, 2024 (GLOBE NEWSWIRE)
Enovis Conclui Aquisição da LimaCorporate S.p.A
January 4, 2024
WILMINGTON, Del., Jan. 03, 2024 (GLOBE NEWSWIRE) — A Enovis™ Corporation (NYSE: ENOV, “Enovis” ou a “Empresa”) uma empresa de
Enovis Conclui Aquisição da LimaCorporate S.p.A
January 4, 2024
WILMINGTON, Del., Jan. 03, 2024 (GLOBE NEWSWIRE) — A Enovis™ Corporation (NYSE: ENOV, “Enovis” ou a “Empresa”) uma empresa de
80 pays autour de la Table ronde ministérielle
January 4, 2024
Le FMF renforce le leadership du royaume saoudien et permet à la super région de contribuer à la construction de
Oitenta países participam da Mesa Redonda Ministerial
January 4, 2024
O FMF consolida a liderança do Reino Unido, permitindo que a Super Região contribua para o setor metalúrgico do futuro
Enovis finalise l’acquisition de LimaCorporate S.p.A.
January 4, 2024
WILMINGTON, Delaware, 03 janv. 2024 (GLOBE NEWSWIRE) — Enovis™ Corporation (NYSE : ENOV, « Enovis » ou la « société
